1-3 of 3
Eugenio Lucia
Close
Sort by
Journal Articles

The Chemotherapy-Free Combination of Vemurafenib and Rituximab Produces Deep and Durable Responses in Relapsed or Refractory Hairy Cell Leukemia (HCL) Patients

Enrico Tiacci, Luca De Carolis, Francesco Zaja, MD, Monia Capponi, Achille Ambrosetti, Eugenio Lucia, Agostino Antolino, Alessandro Pulsoni, MD, Samantha Ferrari, MD, Pier Luigi Zinzani, MD, Luigi Rigacci, Gianluca Gaidano, MD PhD, Roberta Della Seta, Natalia Frattarelli, Paolo Falcucci, Giuseppe Visani, Robin Foà, MD, Brunangelo Falini, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 409.
https://doi.org/10.1182/blood.V130.Suppl_1.409.409
Published: 2017
Journal Articles

Vemurafenib Plus Rituximab in Hairy Cell Leukemia: A Promising Chemotherapy-Free Regimen for Relapsed or Refractory Patients

Enrico Tiacci, Luca De Carolis, Francesco Zaja, Achille Ambrosetti, MD, Eugenio Lucia, Agostino Antolino, Alessandro Pulsoni, MD, Samantha Ferrari, MD, Pier Luigi Zinzani, Gianluca Gaidano, MD PhD, Robin Foà, Brunangelo Falini
Journal: Blood
Blood (2016) 128 (22): 1214.
https://doi.org/10.1182/blood.V128.22.1214.1214
Published: 2016
Journal Articles

Definition of a Prognostic Scoring System for Predicting Clinical Outcome in B-Cell Chronic Lymphocytic Leukemia.

Fortunato Morabito, MD, Giovanna Cutrona, PhD, Massimo Gentile, MD, Serena Matis, PhD, Monica Colombo, PhD, Eugenio Lucia, MD, Mauro Spriano, MD, Edoardo Rossi, MD, Vincenzo Callea, MD, Caterina Stelitano, MD, Carla Mazzone, MD, Ernesto Vigna, MD, Carlo Gentile, MD, Gianluca Festini, MD, Antonino Neri, MD, Simonetta Zupo, PhD, Stefano Molica, MD, Nicholas Chiorazzi, MD, Manlio Ferrarini, MD
Journal: Blood
Blood (2006) 108 (11): 2328.
https://doi.org/10.1182/blood.V108.11.2328.2328
Published: 2006